[
  {
    "ts": null,
    "headline": "Should Myriad Genetics Stock Stay in Your Portfolio Right Now?",
    "summary": "MYGN shows growth potential from new genetic test launches and a refreshed CCC strategy, but revenue pressure from GeneSight coverage loss remains a drag.",
    "url": "https://finnhub.io/api/news?id=40a431d5b06d35776107a5ce8367d7ed537fe7b98173c62e6c1c6c7dc5b5d6ac",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767099960,
      "headline": "Should Myriad Genetics Stock Stay in Your Portfolio Right Now?",
      "id": 137940668,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "MYGN shows growth potential from new genetic test launches and a refreshed CCC strategy, but revenue pressure from GeneSight coverage loss remains a drag.",
      "url": "https://finnhub.io/api/news?id=40a431d5b06d35776107a5ce8367d7ed537fe7b98173c62e6c1c6c7dc5b5d6ac"
    }
  },
  {
    "ts": null,
    "headline": "Should You Continue to Hold EXAS Stock in Your Portfolio Now?",
    "summary": "Exact Sciences is investing heavily in R&D and commercial capabilities to boost Cologuard adoption, but competition and macro pressures cloud the outlook.",
    "url": "https://finnhub.io/api/news?id=e56b4de6d5914a865679a719bd5ec57850be9760e71327fec03020768b6db332",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767097920,
      "headline": "Should You Continue to Hold EXAS Stock in Your Portfolio Now?",
      "id": 137940669,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "Exact Sciences is investing heavily in R&D and commercial capabilities to boost Cologuard adoption, but competition and macro pressures cloud the outlook.",
      "url": "https://finnhub.io/api/news?id=e56b4de6d5914a865679a719bd5ec57850be9760e71327fec03020768b6db332"
    }
  }
]